DCR-004

DCR-004 is a preclinical biomaterial candidate developed by Cellontech for the treatment of cartilage defects. It is part of Cellontech's regenerative medicine pipeline, which focuses on utilizing highly purified collagen (Atelocollagen) to facilitate tissue repair. DCR-004 is designed to function as a biocompatible scaffold that can be applied to chondral lesions, providing a structural framework that supports the migration, adhesion, and proliferation of chondrocytes. By creating an environment conducive to the production of extracellular matrix, the product aims to promote the regeneration of hyaline-like cartilage in joints where natural healing capacity is limited.